Thrombotic microangiopathic syndromes after bone marrow transplantation

Cancer Investigation

Volumn 14, Issue 2, 1996, Pages 151-157

  Byrnes, John J ^a,c   Hussein, Atif M ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; TENIPOSIDE;

BONE MARROW TRANSPLANTATION; CANCER; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0029871535     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609018890     Document Type: Review

References (45)

1. Byrnes JJ, Moake JL: Thrombotic thrombocytopenic purpura and the haemolytic-uremic syndrome: Evolving concepts of pathogenesis and therapy. Clin Haematol 15:413-442, 1986.
2. Rock GA, Shumak K, Buskard NA, et al: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325: 393-397, 1991.
3. Kwaan HC: Miscellaneous secondary thrombotic microangiopathy. Semin Hematol 54:141-147, 1987.
4. Tesh VL, Samuel EJ, Perera LP, et al: Evaluation of the role of shiga and shiga-like toxin in mediating direct damage to human vascular endothelial cells. J Infect Dis 164:344-352, 1991.
5. Ucar A, Fernandez H, Byrnes J, et al: Thrombotic microangiopathy and retroviral infections. Am J Hematol 45:304-309, 1994.
6. Doll DC, Yarbro JW: Vascular toxicity associated with antineoplastic agents. Semin Oncol 19(5):580-596, 1992.
7. Gutterman J, Stevenson TD: Treatment of thrombotic thrombocytopenic purpura with vincristine. JAMA 247:1433, 1982.
8. Udvardly M, Rak K: Cyclophosphamide for chronic relapsing thrombotic thrombocytopenic purpura. Lancet 336:1508-1509, 1990.
9. Moake JL, Rudy CK, Troll JH, et al: Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine. Am J Hematol 20:73-79, 1985.
10. Bonsib SM, Ercolani L, Ngheim D, Hamilton HE: Recurrent thrombotic microangiopathy in a renal allograft: Case report and review of the literature. Am J Med 79:520-527, 1985.
11. Dzik WH, Georgi BA, Khetry U, Jenkins RL: Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation - Successful treatment with plasma exchange. Transplantation 44:570-571, 1987.
12. Grace AA, Barradas MA, Mikhailidis DP, Jeremy JY, Moorhead JF, Sweny P, Dandona P: Cyclosporine A enhances platelet aggregation. Kidney Int 32:889-895, 1987.
13. Brown Z, Neild GH: Cyclosporine inhibits prostacyclin production by cultured human endothelial cells. Transplant Proc 19(1):1178-1180, 1987.
14. Schmidt RJ, Venkat KK, Dumler F: Hemolytic-uremic syndrome in a renal transplant recipient on FK506 immunosuppression. Transplant Proc 23:3156-3157, 1991.
15. IchimashiT, Maoe T, Yoshida H, et al: Hemolytic uremic syndrome during FK 506 therapy. Lancet 330:60-61, 1992.
16. Kierdorf H, Maurin M, Heinz B: Cyclosporine for thrombotic thrombocytopenic purpura. Ann Intern Med 118:987, 1993.
17. DaSilva K, Pasquale D, Tsan MF, Chikkappa G, et al: Cyclosporine A (CyA), an effective therapy for thrombotic thrombocytopenic purpura (TTP). Blood 82(Suppl):411a, 1993.
18. Gable PS, Smith WS, Millard FE: Cyclosporine in relapsed thrombotic thrombocytopenia purpura. Blood 82(Suppl):604a, 1993.
19. Steele BT, Lirenman DS: Acute radiation nephritis and the hemolytic uremic syndrome. Clin Nephrol 11(5):272-274, 1979.
20. Powles RL, Clink HM, Spence D, Morgenstern G, et al: Cyclosporine A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet 1:327-329, 1980.
21. Shulman H, Striker G, Deeg JH, et al: Nephrotoxicity of Cyclosporine A after allogeneic marrow transplantation: Glomerular thrombosis and tubular injury. N Engl J Med 305:1392-1395, 1981.
22. Spruce WE, Forman SJ, Blume KG: Hemolytic uremic syndrome after bone marrow transplantation. Acta Haematol 67:206-210, 1982.
23. Atkinson K, Biggs JC, Hayes J, et al: Cyclosporine A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: Three distinct syndromes. Br J Haematol 54:59-67, 1983.
24. Hows JM, Smith JM, Baughan A, Gordon Smith EC: Nephrotoxicity in marrow graft recipients treated with cyclosporine. Transplant Proc 15(Suppl 1):2708-2711, 1983.
25. Bergstein J, Andreoli SP, Provisor AJ, et al: Radiation nephritis following total-body irradiation and cyclophosphamide in preparation for bone marrow transplantation. Transplantation 41:63-66, 1986.
26. Marshall RJ, Sweny P: Haemolytic-uremic syndrome in recipients of bone marrow transplant not treated with cyclosporine A. Histopathology 10:953-962, 1986.
27. Craig J, Sheehan T, Bell K: The haemolytic uremic syndrome and bone marrow transplantation. Br Med J 295:887, 1987.
28. Guinan EC, Tarbell NJ, Neimeyer CM, et al: Intravenous hemolysis and renal insufficiency after bone marrow transplantation. Blood 72:451-455, 1988.
29. Chappell ME, Keeling DM, Prentice HG, et al: Haemolytic uremic syndrome after bone marrow transplantation: An adverse effect of total body irradiation? Bone Marrow Transplant 3:339-347, 1988.
30. Antignac C, Gubler M-C, Leverger G, et al: Delayed renal failure with extensive mesangiolysis following bone marrow transplant. Kidney Int 35:1336-1344, 1989.
31. Loomis LJ, Aronson AJ, Rudinsky R, et al: Hemolytic uremic syndrome following bone marrow transplantation: A case report and review of the literature. Am J Kidney Dis 14:324-328, 1989.
32. Cohen H, Bull HA, Seddon A, et al: Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation. Eur J Haematol 43: 207-214, 1989.
33. Holler E, Kolb HJ, Hiller E, et al: Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identieal bone marrow transplantation. Blood 73:2018-2024, 1989.
34. Tschuchnigg M, Bradstock KF, Koutts J. et al: A case of thrombotic thrombocytopenic purpura following allogeneic bone marrow transplantation. Bone Marrow Transplant 5:61-63, 1990.
35. Juckett M, Perry EH, Daniels BS, et al: Hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 7:405-409, 1991.
36. Rabinowe SN, Soiffer RJ, Tarbell NJ, et al: Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies. Blood 77:1837-1844, 1991.
37. Silva VA, Frei-Lahr D, Brown RA, et al: Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation. J Clin Apheresis 6:16-20, 1991.
38. Johnson PRE, Liu Lin IA, Drayson MT: Thrombotic thrombocytopenic purpura following allogeneic bone marrow transplantation. Bone Marrow Transplant 7:321-325, 1991.
39. Sarode R, McFarland JG, Flomenberg N, et al: Therapeutic plasma exchange not effective in the management of TTP/HUS following bone marrow transplantation. Blood 82(Suppl):419a, 1993.
40. Collins PW, Gutteridge A, O'Driscoll A, et al: Von Willebrand factor as a marker of endothelial cell activation following BMT. Bone Marrow Transplant 10:499-506, 1992.
41. Brown Z, Neild G, Willoughby JJ, Somia NV, Cameron SJ: Increased factor VIII as an index of vascular injury in cyclosporin nephrotoxicity. Transplantation 42:150-153, 1986.
42. Sporn LA, Rubin P, Marder VJ, Wagner DD: Irradiation induces release of von Willebrand protein from endothelial cells in culture. Blood 64:567-570, 1984.
43. Tarbel NJ, Guinan EC, Niemeyer C, Mauch P, Sallan SE, Weinstein HJ: Late onset of renal dysfunction in survivors of bone marrow transplantation. Int J Radiat Oncol 15:99-104, 1988.
44. Nizze H, Mihatsch MJ, Zollinger HU, Brocheriou C, Gokel JM, Henry K, Sloane JP, Stovin PG: Cyclosporine associated nephropathy in patients with heart and bone marrow transplants. Clin Nephrol 30:248-260, 1988.
45. Crosson JT, Keane WF, Anderson WR: Radiation Nephropathy. In: Renal Pathology, Vol I, edited by CC Tisher, BM Brenner, Philadelphia, JB Lippincott, 1989, pp 866-876.